References
Stein J, Stier C, Raab H, Weiner R (2014) The nutritional and pharmacological consequences of obesity surgery. Aliment Pharmacol Ther 40:582–609
Liu X, Ma Q, Zhang F (2010) Therapeutic drug monitoring in highly active antiretroviral therapy. Expert Opin Drug Saf 9:743–758
Fabbiani M, Di Giambenedetto S, Bracciale L, Bacarelli A, Ragazzoni E, Cauda R, Navarra P, De Luca A (2009) Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice. J Antimicrob Chemother 64:109–117
Benet LZ, Broccatelli F, Oprea TI (2011) BDDCS applied to over 900 drugs. AAPS J 13:519–547
Goldsmith DR, Perry CM (2003) Atazanavir. Drugs 63:1679–1695
Boffito M, Lucchini A, Maiello A, Dal Conte I, Hoggard PG, Back DJ, Di Perri G (2003) Lopinavir/ritonavir absorption in a gastrectomized patient. AIDS 17:136–137
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Gervasoni, C., Cattaneo, D., Resnati, C. et al. The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir. Eur J Clin Pharmacol 73, 789–790 (2017). https://doi.org/10.1007/s00228-017-2231-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2231-5